Skip to main content
. 2019 Jan 23;2019:3951574. doi: 10.1155/2019/3951574

Table 4.

Diagnostic performances of TE, US, and TE combined with US in CHB patients with NAFLD for liver fibrosis and cirrhosis assessment.

Statistic TE US TE plus US

Significant fibrosis assessment (F≥2)
AUC 0.84 (0.75, 0.91) 0.73 (0.63, 0.82) 0.85 (0.76, 0.92)
Standard error 0.042 0.051 0.043
Cut-off value 6.6 6 0.61
Sensitivity (%) 78.7 (64.3, 89.3) 59.6 (44.3, 73.6) 70.2 (55.1, 82.7)
Specificity (%) 76.6 (62.0, 87.7) 80.9 (66.7, 90.9) 95.7 (85.5, 99.5)
PPV (%) 77.1 (62.7, 88.0) 75.7 (58.8, 88.2) 94.3 (80.8, 99.3)
NPV (%) 78.3 (63.6, 89.1) 66.7 (52.9, 78.6) 76.3 (63.4, 86.4)
Positive LR 3.36 (2.0, 5.8) 3.11 (1.7, 5.9) 16.50 (4.2, 64.9)
Negative LR 0.28 (0.2, 0.5) 0.50 (0.3, 0.7) 0.31 (0.2, 0.5)
Advanced fibrosis assessment (F≥3)
AUC 0.95 (0.89, 0.98) 0.76 (0.66, 0.84) 0.95 (0.89, 0.99)
Standard error 0.024 0.052 0.026
Cut-off value 8.7 6 0.39
Sensitivity (%) 83.9 (66.3, 94.5) 67.7 (48.6, 83.3) 87.1 (70.2, 96.4)
Specificity (%) 96.8 (89.0, 99.6) 74.6 (62.1, 84.7) 95.2 (86.7, 99.0)
PPV (%) 92.9 (76.5, 99.1) 56.8 (39.5, 72.9) 90.0 (73.5, 97.9)
NPV (%) 92.4 (83.2, 97.5) 82.5 (70.1, 91.3) 93.7 (84.8, 98.3)
Positive LR 26.4 (6.7, 104.2) 2.7 (1.6, 4.3) 18.3 (6.0, 55.6)
Negative LR 0.17 (0.07, 0.4) 0.43 (0.3, 0.7) 0.14 (0.05, 0.3)
Cirrhosis assessment (F=4)
AUC 0.96 (0.90, 0.99) 0.71 (0.61, 0.80) 0.96 (0.90, 0.99)
Standard error 0.023 0.071 0.022
Cut-off value 10.9 7 0.14
Sensitivity (%) 92.9 (66.1, 99.8) 50.0 (23.0, 77.0) 92.9 (66.1, 99.8)
Specificity (%) 93.8 (86.0, 97.9) 85.0 (75.3, 92.0) 93.8 (86.0, 97.9)
PPV (%) 72.2 (46.5, 90.3) 36.8 (16.3, 61.6) 72.2 (46.5, 90.3)
NPV (%) 98.7 (92.9, 100.0) 90.7 (81.7, 96.2) 98.7 (92.9, 100.0)
Positive LR 14.9 (6.3, 35.1) 3.3 (1.6, 7.0) 14.9 (6.3, 35.1 )
Negative LR 0.08 (0.01, 0.5) 0.59 (0.3, 1.0) 0.08 (0.01, 0.5)

Data in parentheses were 95% confidence interval. AUC=area under the ROC curve. PPV=positive predictive value. NPV=negative predictive value. LR=likelihood ratio.